PF-04620110

DB14887InvestigationalSmall molecule

PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).

Chemical structure of PF-04620110
Formula / weight
C21H24N4O4 · 396.447 g/mol (avg)
Code names
PF-04620110

Resolves to

Compound
UNIICQ4M18RLJWCAS1109276-89-2ChEMBLCHEMBL1835919
Structure
InChIKeyGEVVQZHMFVFGLN-HDJSIYSDSA-NSMILESNC1=NC=NC2=C1C(=O)N(CCO2)C1=CC=C(C=C1)[C@H]1CC[C@H](CC(O)=O)CC1
Targets
O75907DGAT1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-04620110, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In